Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.zenotechlab.com | |
Market Cap | 394.50 Cr. | |
Enterprise Value(EV) | 403.11 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.85 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 34.89 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.01 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 14.74 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.39 | Calculated using Price: 64.64 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 6.10 Cr. | 61,030,568 Shares |
FaceValue | 10 | |
About Zenotech Laboratories Ltd. | ||
Zenotech Laboratories Ltd, formerly known as Sunline Technologies Limited, was originally incorporated as Maa Shakti Tube Mill private Limited on June 15,1989. Zenotech develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs around the world. |
1 Day |
|
-2.92% |
1 Week |
|
-7.49% |
1 Month |
|
+3.62% |
3 Month |
|
-11.86% |
6 Month |
|
-6.87% |
1 Year |
|
+22.48% |
2 Year |
|
+10.65% |
5 Year |
|
+189.48% |
10 Year |
|
+163.43% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 0 | 0 | 0 | -7.73 | 24.35 | -2.48 | 37.26 | 15.15 | |
Return on Capital Employed (%) | -61.52 | -65.68 | 0 | -61.88 | -5.95 | 18.32 | 0.48 | 15.26 | 18.39 | |
Return on Assets (%) | -45.43 | -32.82 | -38.33 | -17.89 | -3.76 | 12.67 | -1.42 | 26.45 | 13.37 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | -27 | -46 | -66 | 42 | 39 | 50 | 48 | 71 | 82 | 87 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 22 | -4 | -7 | -6 | |
Curr. Liab. | 91 | 99 | 116 | 39 | 45 | 35 | 15 | 16 | 17 | 15 | |
Minority Int. | |||||||||||
Equity & Liab. | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 | 92 | 96 | |
Non Curr. Assets | 55 | 50 | 49 | 50 | 65 | 80 | 79 | 74 | 75 | 74 | |
Curr. Assets | 8 | 3 | 2 | 31 | 19 | 6 | 7 | 7 | 16 | 22 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 | 92 | 96 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 4 | 2 | 2 | 11 | 13 | 26 | 22 | 37 | 42 | 43 | |
Other Income | 0 | 0 | 0 | 2 | 5 | 1 | 0 | 1 | 1 | 1 | |
Total Income | 4 | 2 | 2 | 14 | 18 | 27 | 23 | 37 | 44 | 44 | |
Total Expenditure | -24 | -10 | -13 | -19 | -17 | -17 | -16 | -19 | -22 | -23 | |
PBIDT | -20 | -8 | -10 | -6 | 1 | 10 | 7 | 18 | 22 | 20 | |
Interest | -7 | -8 | -8 | -2 | 0 | -1 | -2 | -1 | 0 | ||
Depreciation | -4 | -4 | -4 | -4 | -4 | -5 | -6 | -7 | -7 | -7 | |
Taxation | 12 | -3 | -2 | ||||||||
Exceptional Items | 2 | 6 | |||||||||
PAT | -30 | -19 | -20 | -12 | -3 | 11 | -1 | 22 | 12 | 11 | |
Adjusted EPS | -8 | -5 | -5 | -2 | -1 | 2 | 0 | 4 | 2 | 2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -24 | -8 | -5 | 2 | -16 | -14 | 11 | 6 | 18 | 21 | |
Cash Fr. Inv. | -1 | 0 | 6 | -1 | -3 | -16 | -21 | -5 | -2 | -6 | |
Cash Fr. Finan. | 30 | 7 | -1 | -1 | 47 | 15 | -3 | 0 | -16 | -6 | |
Net Change | 5 | -1 | 0 | 0 | 28 | -15 | -12 | 1 | 0 | 9 | |
Cash & Cash Eqvt | 6 | 6 | 0 | 0 | 28 | 13 | 1 | 2 | 2 | 11 |
Sat, 06 Apr 2024
Shareholder Meeting / Postal Ballot-Outcome of AGM As per attached letter |
Sat, 06 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2024 |
Sat, 06 Apr 2024
Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended March 31 2024 Attached Compliance Certificate dated April 05 2024 under Regulaion 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 |
Thu, 18 Apr 2024 |
Making Higher Highs for 2 Days |
High Increase in 1 Month |
High Increase in 5 Years |
William %R Trending Down |
Close Below Last Week Low |